Ardelyx, Inc. ARDX 深 沪
等待开盘 04-01 09:30:00 美东时间
5.99
+0.440
+7.93%
华盛通- 最 高6.04
- 今 开5.69
- 成交量 547.27万股
- 最 低 5.685
- 昨 收 5.55
- 总市值 14.68亿
- 52周最高 8.40
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 3.21
- 委 比 -99.92%
- 总股本 2.45亿
- 历史最高 35.48
- 量 比 1.82
- 振 幅 6.40%
- 历史最低 0.49
- 每 手 1
- 风险率 1.12%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Ardelyx Data From IBS-C Clinical Development Program Demonstrates Tenapanor Offers Rapid, Sustained Relief For Adults With IBS-C
Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced the publication of data from
03-10 04:12
美股大行评级 | 大摩将康宁目标价从103美元升至127美元；潜在涨幅1779.7%！IGC Pharma获Ascendiant Capital升目标价至5美元
今日重点评级关注：Ascendiant Capital：维持IGC Pharma"买入"评级，目标价从4.75美元升至5美元；Brookline Capital：维持C4 Therapeutics"买入"评级，目标价从20美元升至30美元
02-24 10:27
美股大行评级 | 潜在涨幅214.14%！HC Wainwright & Co.：Ardelyx获机构升目标价至18美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Ardelyx"买入"评级，目标价从10美元升至18美元；Truist Securities：维持Praxis Precision Medicine"买入"评级，目标价从500美元升至700美元
02-23 08:56
Ardelyx Lead Drug Growth Fails To Lift Sentiment, Stock Drops
Ardelyx stock drops premarket despite revenue beat as investors weigh IBSRELA growth outlook and mixed technical signals heading into 2026.
02-20 19:50
HC Wainwright & Co. Maintains Buy on Ardelyx, Raises Price Target to $18
HC Wainwright & Co. analyst Matthew Caufield maintains Ardelyx (NASDAQ:ARDX) with a Buy and raises the price target from $10 to $18.
02-20 19:39
财报速睇 | Ardelyx, Inc. 2025财年Q4营收1.25亿美元，同比增长7.8%；归母净利润亏损0.00亿美元，由盈转亏
华盛资讯2月20日讯，Ardelyx, Inc.公布2025财年Q4业绩，公司Q4营收1.25亿美元，同比增长7.8%，归母净利润亏损0.00亿美元，由盈转亏。
02-20 05:32
Ardelyx Q4 Earnings Report: What Investors Need to Know
Ardelyx (NASDAQ:ARDX) released its Q4 earnings on Thursday, February 19, 2026 a...
02-20 05:04
Earnings Scheduled For February 19, 2026
Companies Reporting Before The Bell • Deere (NYSE:DE) is expected to report qua...
02-19 19:11
Insights Ahead: Ardelyx's Quarterly Earnings
Ardelyx (NASDAQ:ARDX) is set to give its latest quarterly earnings report on Th...
02-19 03:01
美股大行评级 | Meta 、IBM、拉姆研究、布林克国际等获多家机构上调目标价；微软、特斯拉、ServiceNow、自动数据处理等遭多家下调评级
今日重点评级关注：Piper Sandler：上调Korro Bio评级至"超配"，目标价从11美元升至30美元；Piper Sandler：维持Nurix Therapeutics"超配"评级，目标价从32美元升至35美元
01-30 17:38
